News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,656 Results
Type
Article (14387)
Company Profile (282)
Press Release (255987)
Section
Business (80458)
Career Advice (158)
Deals (13344)
Drug Delivery (36)
Drug Development (50717)
Employer Resources (32)
FDA (5758)
Job Trends (5267)
News (145912)
Policy (10240)
Tag
Academia (934)
Alliances (21828)
Alzheimer's disease (807)
Antibody-drug conjugate (ADC) (77)
Approvals (5760)
Artificial intelligence (94)
Bankruptcy (102)
Best Places to Work (4693)
Biotechnology (233)
Breast cancer (130)
Cancer (1119)
Cardiovascular disease (88)
Career advice (139)
CAR-T (93)
Cell therapy (275)
Clinical research (40788)
Collaboration (442)
Compensation (184)
COVID-19 (1050)
C-suite (118)
Cystic fibrosis (74)
Data (1157)
Diabetes (106)
Diagnostics (1338)
Earnings (29517)
Events (50863)
Executive appointments (353)
FDA (6266)
Funding (418)
Gene editing (76)
Gene therapy (199)
GLP-1 (340)
Government (1137)
Healthcare (6833)
Infectious disease (1105)
Inflammatory bowel disease (105)
IPO (7292)
Job creations (873)
Job search strategy (133)
Layoffs (197)
Legal (1443)
Lung cancer (165)
Manufacturing (105)
Medical device (2689)
Medtech (2690)
Mergers & acquisitions (6287)
Metabolic disorders (319)
Neuroscience (1122)
NextGen: Class of 2025 (2128)
Non-profit (984)
Northern California (1349)
Obesity (170)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25677)
Phase I (14378)
Phase II (18963)
Phase III (12024)
Pipeline (507)
Postmarket research (868)
Preclinical (6034)
Radiopharmaceuticals (211)
Rare diseases (249)
Real estate (1442)
Regulatory (8535)
Research institute (959)
Series A (82)
Southern California (1194)
Startups (1978)
United States (10693)
Vaccines (198)
Weight loss (99)
Date
Today (5)
Last 7 days (347)
Last 30 days (1483)
Last 365 days (20628)
2025 (2677)
2024 (20809)
2023 (22728)
2022 (27172)
2021 (28292)
2020 (23833)
2019 (17048)
2018 (12353)
2017 (13978)
2016 (12180)
2015 (14683)
2014 (10602)
2013 (7659)
2012 (7784)
2011 (7852)
2010 (7607)
Location
Africa (155)
Asia (17454)
Australia (2942)
California (3070)
Canada (972)
China (269)
Colorado (125)
Connecticut (134)
Delaware (72)
Europe (37335)
Florida (351)
Georgia (91)
Illinois (199)
Indiana (80)
Maryland (402)
Massachusetts (2431)
Minnesota (121)
New Jersey (774)
New York (844)
North Carolina (476)
Northern California (1349)
Ohio (99)
Pennsylvania (587)
South America (216)
Southern California (1194)
Texas (346)
Washington State (294)
270,656 Results for "summit therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lisata Therapeutics to Present at the 2025 Sequire Investor Summit
January 15, 2025
·
2 min read
Lung cancer
Despite Win Over Keytruda, Summit’s NSCLC Bispecific Still Has Something to Prove
Summit Therapeutics’ ivonescimab has the potential to challenge Merck’s blockbuster checkpoint inhibitor in non-small cell lung cancer, but experts stress the need for diverse and overall survival data.
September 18, 2024
·
5 min read
·
Kate Goodwin
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 14, 2025
February 17, 2025
·
4 min read
Press Releases
Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025
February 18, 2025
·
4 min read
Press Releases
Summit Therapeutics to Present at Upcoming Investor Conferences
November 26, 2024
·
7 min read
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2025
·
4 min read
Press Releases
Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
7 min read
Business
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
June 27, 2024
·
8 min read
Press Releases
Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
January 9, 2025
·
2 min read
Press Releases
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
November 26, 2024
·
3 min read
1 of 27,066
Next
